Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOGEN INC. Director's Dealing 2018

Jun 14, 2018

30291_dirs_2018-06-14_8c586b05-e20d-41c0-9710-3f16c4b38737.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOGEN INC. (BIIB)
CIK: 0000875045
Period of Report: 2018-06-12

Reporting Person: PAPADOPOULOS STELIOS (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2018-06-12 Common Stock A 1450 Acquired 3190 Direct

Holdings (Non-Derivative)

Security Shares Ownership
Common Stock 10831 Indirect
Common Stock 17375 Indirect

Footnotes

F1: The reporting person transferred 5,831 shares that he directly owned to Esperanza Holdings, LLC.

F2: The reporting person transferred 12,375 shares that he directly owned to Stelios Holdings, LLC.